There is no doubt that our study is the first meta-analysis including ten published studies with 1995 patients to comprehensively evaluate the survival value of XRCC1 (SNPs and high protein expression) in HNSCC. This evidence concerns the gene XRCC1 and head and neck squamous cell carcinoma.